These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26005026)

  • 1. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
    Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
    Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling and synthesis of spiroimidazolidine-2,4-diones with dual activities as hypoglycemic agents and selective inhibitors of aldose reductase.
    Salem MG; Abdel Aziz YM; Elewa M; Elshihawy HA; Said MM
    Bioorg Chem; 2018 Sep; 79():131-144. PubMed ID: 29751319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.
    Salem MG; Aziz YMA; Elewa M; Elshihawy HA; Said MM
    Bioorg Med Chem; 2019 Aug; 27(15):3383-3389. PubMed ID: 31221611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides.
    Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM
    Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.
    Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles.
    Patnam N; Chevula K; Chennamsetti P; Aleti B; Kotha AK; Manga V
    Mol Divers; 2024 Jun; 28(3):1551-1563. PubMed ID: 37326778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
    Huang W; Zhang Y; Liang X; Yang L
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual action spirobicycloimidazolidine-2,4-diones: antidiabetic agents and inhibitors of aldose reductase-an enzyme involved in diabetic complications.
    Iqbal Z; Ali S; Iqbal J; Abbas Q; Qureshi IZ; Hameed S
    Bioorg Med Chem Lett; 2013 Jan; 23(2):488-91. PubMed ID: 23246355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
    Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
    Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
    J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of indole-substituted thiosemicarbazones as an aldose reductase inhibitor: an 
    Shehzad MT; Khan A; Halim SA; Hameed A; Imran A; Iqbal J; Ullah A; Asari A; Khan S; Shafiq Z; Al-Harrasi A
    Future Med Chem; 2021 Jul; 13(14):1185-1201. PubMed ID: 34148377
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors.
    Ovais S; Pushpalatha H; Reddy GB; Rathore P; Bashir R; Yaseen S; Dheyaa A; Yaseen R; Tanwar O; Akthar M; Samim M; Javed K
    Eur J Med Chem; 2014 Jun; 80():209-17. PubMed ID: 24780598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
    Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
    Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
    Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetic acid derivatives of 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors.
    Chen X; Zhu C; Guo F; Qiu X; Yang Y; Zhang S; He M; Parveen S; Jing C; Li Y; Ma B
    J Med Chem; 2010 Dec; 53(23):8330-44. PubMed ID: 21062005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
    Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
    Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.
    Javid N; Munir R; Chaudhry F; Imran A; Zaib S; Muzaffar A; Iqbal J
    Bioorg Chem; 2020 Jun; 99():103852. PubMed ID: 32325339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
    Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
    Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.